The ability of tau aggregates to differentially seed formation of structurally analogous inclusions in recipient cells suggests that the heterogenous clinical and pathological features of tauopathies may be defined by distinct tau “strains” [44–48]. This evidence concerns the gene MAPT and tauopathy.